06.05.2019 • NewsElaine BurridgeExxonMobil

ExxonMobil OK’s Baytown Expansion

ExxonMobil OK’s Baytown Expansion (c) Exxonmobil
ExxonMobil OK’s Baytown Expansion (c) Exxonmobil

ExxonMobil has announced it will proceed with a $2 billion investment to expand production in Baytown, Texas, USA.

The energy and chemicals major will build a 400,000 t/y Vistamaxx performance polymer plant as well as a 350,000 t/y linear alpha olefins (LAO) facility. The expansion, which will mark ExxonMobil’s entry into the LAO market, is expected to go online in 2022.

“Our Baytown chemical expansion will put us in a solid position to maximize the value of increased Permian Basin production and will deliver higher-demand, higher-value products produced at our Gulf Coast refining and chemical facilities,” said CEO Darren Woods. “Global demand for chemicals is expected to be greater than energy demand growth and GDP growth over the next 20 years.”

The project is in addition to ExxonMobil’s Growing the Gulf Initiative, which it launched in 2017 to build and expand manufacturing facilities along the US Gulf Coast. The group is aiming to spend $20 billion over 10 years to build and expand 11 manufacturing facilities, including increasing oil production in the Permian Basin.

Last year, ExxonMobil formed a joint venture with SABIC to build an ethane-based complex in San Patricio County, Texas, comprising a 1.8 million t/y cracker, a monoethylene glycol plant and two PE units. The complex is anticipated to start production in 2021-2022.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.